These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28870924)

  • 1. Role of Caspase-9 Gene Ex5+32 G>A (rs1052576) Variant in Susceptibility to Primary Brain Tumors.
    Ozdogan S; Kafadar A; Yilmaz SG; Timirci-Kahraman O; Gormus U; Isbir T
    Anticancer Res; 2017 Sep; 37(9):4997-5000. PubMed ID: 28870924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 gene G870A variants and primary brain tumors.
    Zeybek U; Yaylim I; Ozkan NE; Korkmaz G; Turan S; Kafadar D; Cacina C; Kafadar AM
    Asian Pac J Cancer Prev; 2013; 14(7):4101-6. PubMed ID: 23991960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and Effects of CDKN2 p16 540 C>G and 580 C>T, and MDM2 SNP309 T>G Polymorphisms in Patients with Primary Brain Tumors.
    Kafadar A; Küçükhüseyin Ö; Turan S; Yenilmez EN; Tunoglu S; Zeybek U; Kaynar MY; Kemerdere R; Yaylim I
    Anticancer Res; 2015 Jul; 35(7):3933-42. PubMed ID: 26124340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between FAS and FASL genetic variants and risk of primary brain tumor.
    Dalan AB; Timirci-Kahraman O; Turan S; Kafadar AM; Yaylim I; Ergen A; Gormus U; Gulec-Yilmaz S; Kaspar C; Isbir T
    Int J Neurosci; 2014 Jun; 124(6):443-9. PubMed ID: 24094130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XRCC1 and XRCC3 variants and risk of glioma and meningioma.
    Kiuru A; Lindholm C; Heinävaara S; Ilus T; Jokinen P; Haapasalo H; Salminen T; Christensen HC; Feychting M; Johansen C; Lönn S; Malmer B; Schoemaker MJ; Swerdlow AJ; Auvinen A
    J Neurooncol; 2008 Jun; 88(2):135-42. PubMed ID: 18330515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma.
    Bethke L; Webb E; Murray A; Schoemaker M; Feychting M; Lönn S; Ahlbom A; Malmer B; Henriksson R; Auvinen A; Kiuru A; Salminen T; Johansen C; Christensen HC; Muir K; McKinney P; Hepworth S; Dimitropoulou P; Lophatananon A; Swerdlow A; Houlston R
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1195-202. PubMed ID: 18483342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma.
    Rajaraman P; Hutchinson A; Wichner S; Black PM; Fine HA; Loeffler JS; Selker RG; Shapiro WR; Rothman N; Linet MS; Inskip PD
    Neuro Oncol; 2010 Jan; 12(1):37-48. PubMed ID: 20150366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 Genotypes and risk of glioma and meningioma.
    Malmer B; Feychting M; Lönn S; Ahlbom A; Henriksson R
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2220-3. PubMed ID: 16172235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of ICAM-1 and β3 integrin gene variations in patients with brain tumors.
    Yilmaz U; Zeybek U; Kahraman OT; Kafadar AM; Toptas B; Yamak N; Celik F; Yaylim I
    Asian Pac J Cancer Prev; 2013; 14(10):5929-34. PubMed ID: 24289603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults.
    Rajaraman P; Wang SS; Rothman N; Brown MM; Black PM; Fine HA; Loeffler JS; Selker RG; Shapiro WR; Chanock SJ; Inskip PD
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1655-61. PubMed ID: 17684142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of CASP8 D302H Gene Variants in Patients with Primary Brain Tumors.
    Cacina C; Pence S; Turan S; Genc F; Ozdemir H; Kafadar A; Kaynar MY; Yaylim I
    In Vivo; 2015; 29(5):601-4. PubMed ID: 26359420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C677T gene polymorphism of methylenetetrahydrofolate reductase (MTHFR) in meningiomas and high-grade gliomas.
    Kafadar AM; Yilmaz H; Kafadar D; Ergen A; Zeybek U; Bozkurt N; Kuday C; Isbir T
    Anticancer Res; 2006; 26(3B):2445-9. PubMed ID: 16821630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CASP-9 gene functional polymorphisms and cancer risk: a large-scale association study plus meta-analysis.
    Zhang ZY; Xuan Y; Jin XY; Tian X; Wu R
    Genet Mol Res; 2013 Feb; 12(3):3070-8. PubMed ID: 23479167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lead, genetic susceptibility, and risk of adult brain tumors.
    Rajaraman P; Stewart PA; Samet JM; Schwartz BS; Linet MS; Zahm SH; Rothman N; Yeager M; Fine HA; Black PM; Loeffler J; Shapiro WR; Selker RG; Inskip PD
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2514-20. PubMed ID: 17164378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.
    Ghasimi S; Wibom C; Dahlin AM; Brännström T; Golovleva I; Andersson U; Melin B
    J Neurooncol; 2016 May; 127(3):483-92. PubMed ID: 26839018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms and haplotypes in caspases 8 and 9 genes and risk for prostate cancer: a case-control study in cohort of North India.
    George GP; Mandal RK; Kesarwani P; Sankhwar SN; Mandhani A; Mittal RD
    Urol Oncol; 2012; 30(6):781-9. PubMed ID: 21396853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased frequency of rapid acetylator genotypes in patients with brain astrocytoma and meningioma.
    Olivera M; Martínez C; Molina JA; Alonso-Navarro H; Jiménez-Jiménez FJ; García-Martín E; Benítez J; Agúndez JA
    Acta Neurol Scand; 2006 May; 113(5):322-6. PubMed ID: 16629768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma.
    Malmer BS; Feychting M; Lönn S; Lindström S; Grönberg H; Ahlbom A; Schwartzbaum J; Auvinen A; Collatz-Christensen H; Johansen C; Kiuru A; Mudie N; Salminen T; Schoemaker MJ; Swerdlow AJ; Henriksson R
    J Neurooncol; 2007 May; 82(3):229-37. PubMed ID: 17151932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare HRAS1 alleles are a risk factor for the development of brain tumors.
    Vega A; Sobrido MJ; Ruiz-Ponte C; Barros F; Carracedo A
    Cancer; 2001 Dec; 92(11):2920-6. PubMed ID: 11753967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Caspase 9 Gene Polymorphism in Patients with Prostate Cancer.
    Yilmaz SG; Yencilek F; Yildirim A; Yencilek E; Isbir T
    In Vivo; 2017; 31(2):205-208. PubMed ID: 28358701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.